All Stories

  1. Implementation and Outcome of Clinical Pharmacist-led Anticoagulation Clinic at Cardiac Center: A Retrospective Cohort Study

    Article • Saudi Journal of Clinical Pharmacy, July 2024, Medknow

    Dr. Ali Faris Altebainawi

  2. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

    Article • BMC Infectious Diseases, February 2024, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  3. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study

    Article • Scientific Reports, February 2024, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  4. EE173 Budget Impact Analysis of IDegAsp for the Management of Type 2 Diabetes in Saudi Arabia

    Article • Value in Health, December 2023, Elsevier

    Dr. Ali Faris Altebainawi

  5. The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study

    Article • Renal Failure, October 2023, Taylor & Francis

    Dr. Ali Faris Altebainawi

  6. Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study

    Article • BMC Pulmonary Medicine, October 2023, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  7. When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study

    Article • Journal of Infection and Public Health, September 2023, Elsevier

    Dr. Ali Faris Altebainawi

  8. Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study

    Article • BMC Pulmonary Medicine, August 2023, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  9. Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19—A multicenter cohort study

    Article • Frontiers in Medicine, August 2023, Frontiers

    Dr. Ali Faris Altebainawi

  10. The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

    Article • Saudi Pharmaceutical Journal, July 2023, Elsevier

    Dr. Ali Faris Altebainawi

  11. Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study

    Article • BMC Infectious Diseases, February 2023, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  12. The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study

    Article • BMC Infectious Diseases, February 2023, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  13. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study

    Article • Journal of Intensive Care Medicine, January 2023, SAGE Publications

    Dr. Ali Faris Altebainawi

  14. Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

    Article • Therapeutic Advances in Drug Safety, January 2023, SAGE Publications

    Dr. Ali Faris Altebainawi

  15. Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2023, SAGE Publications

    Dr. Ali Faris Altebainawi

  16. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2023, SAGE Publications

    Dr. Ali Faris Altebainawi

  17. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2023, SAGE Publications

    Dr. Ali Faris Altebainawi

  18. Strategies to curtail the burden of cardiovascular diseases during Hajj activities: A review

    Article • Saudi Journal of Clinical Pharmacy, January 2023, Medknow

    Dr. Ali Faris Altebainawi

  19. Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study

    Article • Thrombosis Journal, December 2022, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  20. Health economic burden of COVID-19 in Saudi Arabia

    Article • Frontiers in Public Health, October 2022, Frontiers

    Dr. Ali Faris Altebainawi

  21. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

    Article • Critical Care, October 2022, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  22. The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study

    Article • International Journal of Infectious Diseases, September 2022, Elsevier

    Dr. Ali Faris Altebainawi

  23. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study

    Article • Frontiers in Public Health, August 2022, Frontiers

    Dr. Ali Faris Altebainawi

  24. Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study

    Article • Scientific Reports, June 2022, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  25. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study

    Article • Journal of Intensive Care Medicine, April 2022, SAGE Publications

    Dr. Ali Faris Altebainawi

  26. Health Economic Burden of COVID-19 in Saudi Arabia

    Article • April 2022, Cold Spring Harbor Laboratory Press

    Dr. Ali Faris Altebainawi

  27. Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials

    Article • Saudi Pharmaceutical Journal, March 2022, Elsevier

    Dr. Ali Faris Altebainawi

  28. Implementation of the first pharmacist‐led diabetes clinic at Ministry of Health Hospitals, Saudi Arabia

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, February 2022, Wiley

    Meshal Alnais, Dr. Ali Faris Altebainawi

  29. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2022, SAGE Publications

    Dr. Ali Faris Altebainawi

  30. Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

    Article • December 2021, Research Square

    Dr. Ali Faris Altebainawi

  31. 200: IMPACT OF STATINS ON THE CLINICAL OUTCOMES IN COVID-19 CRITICALLY ILL PATIENTS: A MULTICENTER STUDY

    Article • Critical Care Medicine, December 2021, Wolters Kluwer Health

    Dr. Ali Faris Altebainawi

  32. Early Dexamethasone Use as A Protective Measure In Non-Mechanically Ventilated Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

    Article • November 2021, Research Square

    Dr. Ali Faris Altebainawi

  33. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

    Article • Journal of Intensive Care Medicine, November 2021, SAGE Publications

    Dr. Ali Faris Altebainawi

  34. Evaluation of low-dose aspirin use among COVID-19 critically ill patients: A Multicenter Propensity Score Matched Study

    Article • September 2021, Research Square

    Dr. Ali Faris Altebainawi

  35. Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

    Article • August 2021, Research Square

    Dr. Ali Faris Altebainawi

  36. Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

    Article • August 2021, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  37. Early Versus Late Use of Dexamethasone in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

    Article • July 2021, Research Square

    Dr. Ali Faris Altebainawi

  38. Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide

    Article • Saudi Pharmaceutical Journal, May 2021, Elsevier

    Dr. Ali Faris Altebainawi

  39. Current Situation of Medication Errors in Saudi Arabia: A Nationwide Observational Study

    Article • Journal of Patient Safety, March 2021, Wolters Kluwer Health

    Dr. Ali Faris Altebainawi

  40. Current situation of medication errors in Saudi Arabia: a nationwide observational study

    Article • August 2020, Research Square

    Dr. Ali Faris Altebainawi

  41. Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Dr. Ali Faris Altebainawi

  42. Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example

    Article • Saudi Pharmaceutical Journal, July 2020, Elsevier

    Dr. Ali Faris Altebainawi

  43. Association of medication storage with diabetes control: A cross-sectional study from Saudi Arabia

    Article • Saudi Pharmaceutical Journal, April 2020, Elsevier

    Dr. Ali Faris Altebainawi

  44. Biostatistical analysis knowledge of pharmacy research in the Kingdom of Saudi Arabia

    Article • International Journal of ADVANCED AND APPLIED SCIENCES, March 2020, International Journal of Advanced and Applied Sciences

    Dr. Ali Faris Altebainawi

  45. Basic pharmacy research knowledge in the Kingdom of Saudi Arabia

    Article • International Journal of Medicine in Developing Countries, January 2020, Discover Publishing Group

    Dr. Ali Faris Altebainawi

  46. Completeness of medication prescriptions: Prescription errors study in Hail region, Saudi Arabia (PeSHR)

    Article • International Journal of ADVANCED AND APPLIED SCIENCES, December 2019, International Journal of Advanced and Applied Sciences

    Dr. Ali Faris Altebainawi

  47. Energy drinks and population health: consumption pattern and adverse effects among Saudi population

    Article • BMC Public Health, November 2019, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  48. PNS103 PHARMACY RESEARCH BASIC KNOWLEDGE IN THE KINDOM OF SAUDI ARABIA

    Article • Value in Health, November 2019, Elsevier

    Dr. Ali Faris Altebainawi

  49. 19th ISoP Annual Meeting “New Opportunities for New Generations” Bogotá, Colombia, 26–29 October, 2019

    Article • Drug Safety, September 2019, Springer Science + Business Media

    Dr. Ali Faris Altebainawi

  50. Abstracts

    Article • Pharmacoepidemiology and Drug Safety, August 2019, Wiley

    Dr. Ali Faris Altebainawi

  51. ISPE19 Author Index

    Article • Pharmacoepidemiology and Drug Safety, August 2019, Wiley

    Dr. Ali Faris Altebainawi

  52. Public knowledge, attitude and practice toward diabetes mellitus in Hail region, Saudi Arabia

    Article • International Journal of General Medicine, July 2019, Dove Medical Press

    Dr. Ali Faris Altebainawi

  53. Knowledge and attitude of analgesics use among Saudi population: A cross-sectional study

    Article • International Journal of Medical Science and Public Health, January 2018, ScopeMed International Medical Journal Management and Indexing System

    Dr. Ali Faris Altebainawi

  54. Abstracts

    Article • Pharmacoepidemiology and Drug Safety, September 2015, Wiley

    Dr. Ali Faris Altebainawi